These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35513495)

  • 1. Harnessing the liver to induce antigen-specific immune tolerance.
    Gottwick C; Carambia A; Herkel J
    Semin Immunopathol; 2022 Jul; 44(4):475-484. PubMed ID: 35513495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.
    Richardson N; Ng STH; Wraith DC
    Front Immunol; 2020; 11():1586. PubMed ID: 32793226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for immune tolerance against autoimmune disease.
    Kim A; Xie F; Abed OA; Moon JJ
    Adv Drug Deliv Rev; 2023 Dec; 203():115140. PubMed ID: 37980949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.
    Horst AK; Kumashie KG; Neumann K; Diehl L; Tiegs G
    Cell Mol Immunol; 2021 Jan; 18(1):92-111. PubMed ID: 33110250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view.
    Tajbakhsh A; Farahani N; Gheibihayat SM; Mirkhabbaz AM; Savardashtaki A; Hamblin MR; Mirzaei H
    Int Immunopharmacol; 2021 Jan; 90():107177. PubMed ID: 33249046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity, tolerance and autoimmunity in the liver: A comprehensive review.
    Doherty DG
    J Autoimmun; 2016 Jan; 66():60-75. PubMed ID: 26358406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.
    Almenara-Fuentes L; Rodriguez-Fernandez S; Rosell-Mases E; Kachler K; You A; Salvado M; Andreev D; Steffen U; Bang H; Bozec A; Schett G; Le Panse R; Verdaguer J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
    Nanomedicine; 2023 Feb; 48():102635. PubMed ID: 36481472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
    Griffin JD; Song JY; Huang A; Sedlacek AR; Flannagan KL; Berkland CJ
    Biomaterials; 2019 Nov; 222():119440. PubMed ID: 31450159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity as the trigger of systemic autoimmune diseases.
    Saferding V; Blüml S
    J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
    Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
    Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cells and autoimmune disease.
    Wu L; Van Kaer L
    Curr Mol Med; 2009 Feb; 9(1):4-14. PubMed ID: 19199937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T cells in hepatic immune tolerance.
    Carambia A; Herkel J
    J Autoimmun; 2010 Feb; 34(1):23-8. PubMed ID: 19720498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
    Tisch R; McDevitt HO
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):437-8. PubMed ID: 8290544
    [No Abstract]   [Full Text] [Related]  

  • 19. Tackling autoimmunity with nanomedicines.
    Feng X; Liu J; Xu W; Li G; Ding J
    Nanomedicine (Lond); 2020 Jul; 15(16):1585-1597. PubMed ID: 32669025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary concepts of autoimmunity and autoimmune diseases.
    Nakamura MC; Nakamura RM
    J Clin Lab Anal; 1992; 6(5):275-89. PubMed ID: 1403347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.